Objective The 1980 American College of Rheumatology (ACR) classification criteria for
systemic sclerosis (SSc) lack sensitivity for early SSc and limited cutaneous SSc. The present …

Objective Remission in rheumatoid arthritis (RA) is an increasingly attainable goal, but there
is no widely used definition of remission that is stringent but achievable and could be …

The aim was to update the 2009 European League against Rheumatism (EULAR)
recommendations for the treatment of systemic sclerosis (SSc), with attention to new therapeutic …

Background: Systemic sclerosis (SSc) is a multisystem autoimmune disease, which is classified
into a diffuse cutaneous (dcSSc) and a limited cutaneous (lcSSc) subset according to the …

Objective Recurrent digital ulcers are a manifestation of vascular disease in patients with
systemic sclerosis (SSc; scleroderma) and lead to pain, impaired function, and tissue loss. We …

OBJECTIVE: A survey was performed in 5 European countries (France, Germany, Italy,
Portugal, and Spain) to estimate the prevalence of fibromyalgia (FM) in the general population. …

Background A phase 2 trial of tocilizumab showed preliminary evidence of efficacy in systemic
sclerosis. We assessed skin fibrosis and systemic sclerosis-associated interstitial lung …

Purpose: The optimal treatment of systemic sclerosis (SSc) is a challenge because the
pathogenesis of SSc is unclear and it is an uncommon and clinically heterogeneous disease …

Importance High-dose immunosuppressive therapy and autologous hematopoietic stem cell
transplantation (HSCT) have shown efficacy in systemic sclerosis in phase 1 and small …

Objective. The 1980 American College of Rheuma-tology (ACR) classification criteria for
systemic sclerosis (SSc) lack sensitivity for early SSc and limited cutaneous SSc. The present …